David Miao
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 7
- HER2/EGFR in Cancer Research 6
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Paul W.H.I. Parren (2 shared papers)David Satijn (2 shared papers)Richard Wubbolts (2 shared papers)Bart E.C.G. de Goeij (2 shared papers)Esther C.W. Breij (1 shared paper)Tom Vink (1 shared paper)Tong Zhu (3 shared papers)Alisher Khasanov (1 shared paper)
- Journals
- Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)Science Advances (1 paper)Investigational New Drugs (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
David Miao
8 papers receiving 246 citations
Peers
Comparison fields: 5 of 45
- Radiology, Nuclear Medicine and Imaging 151
- Oncology 163
- Immunology 70
- Immunology and Allergy 13
- Genetics 16
Countries citing papers authored by David Miao
This map shows the geographic impact of David Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Miao more than expected).
Fields of papers citing papers by David Miao
This network shows the impact of papers produced by David Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Miao. The network helps show where David Miao may publish in the future.
Co-authors
The 25 scholars most cited alongside David Miao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 101 | |
| 2 | 2015 | 78 | |
| 3 | 2019 | 53 | |
| 4 | 2013 | 18 | |
| 5 | 2015 | 2 | |
| 6 | 2025 | 1 | |
| 7 | 2015 | 1 | |
| 8 | 2015 | 1 | |
| 9 | 2025 | 0 |
About David Miao
David Miao is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Surgery, Molecular Biology and Genetics, having authored 9 papers that have together received 255 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), interferon and immune responses (1 paper), Inflammatory Bowel Disease (1 paper), Nanofabrication and Lithography Techniques (1 paper), Cell Adhesion Molecules Research (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Pregnancy and Medication Impact (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (151 citations), Oncology (163 citations), Immunology (70 citations), Immunology and Allergy (13 citations) and Genetics (16 citations). David Miao has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Paul W.H.I. Parren, David Satijn, Richard Wubbolts, Bart E.C.G. de Goeij, Esther C.W. Breij, Tom Vink, Tong Zhu, Alisher Khasanov, Gary Chen and Patrick H.C. van Berkel. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Science Advances, Investigational New Drugs and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.